The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide.

@article{McInnes1994TheEI,
  title={The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide.},
  author={P M McInnes and J. A. Schuttinga and W R Sanslone and Stefan Stark and John H Klippel},
  journal={Arthritis and rheumatism},
  year={1994},
  volume={37 7},
  pages={1000-6}
}
OBJECTIVE It has been reported that outcomes are improved in patients with severe lupus nephritis treated with combined prednisone and intravenous cyclophosphamide, compared with those treated with prednisone alone. These findings motivated this analysis of the economic impact of the combined therapy. METHODS The annual expected incidence of severe lupus nephritis in the year 1988 in the US was estimated to be 1,130. A hypothetical patient cohort of this size was used as the model for the… CONTINUE READING